comparemela.com

Latest Breaking News On - A equecabtagene autoleucel - Page 1 : comparemela.com

IASO Bio Presents Updated Long-Term Follow-Up Data for BCMA CAR-T FUCASO® (Equecabtagene Autoleucel) at IMS 2023

/PRNewswire/ IASO Bio, a biopharmaceutical company engaged in discovering, developing, manufacturing and marketing innovative cell therapies and antibody.

Lugui qiuAdimab incyteChunrui liEli lillyA equecabtagene autoleucelEquecabtagene autoleucelInnovent biologicsInnovent biologics incInternational myeloma societyHuazhong university of science technologyChinese academy of medical science hematology hospitalMd anderson cancer centerTongji medical collegeChina national medical products administrationComplete responseAbstract code

IASO Bio Announces CT103A Granted Regenerative Medicine Advanced Therapy (RMAT) and Fast Track (FT) Designations by the FDA

/PRNewswire/ IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative.

Equecabtagene autoleucelA equecabtagene autoleucelChina national medical products administrationDrug administrationInnovent biologics incRegenerative medicine advanced therapyFast trackNew drug applicationBreakthrough therapy designationOrphan drug designationNeuromyelitis optica spectrum disorderInnovent biologicsCentury cures actAccelerated approvalPriority reviewNational medical products administration

vimarsana © 2020. All Rights Reserved.